🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Summit Therapeutics Inc.

Summit Therapeutics Inc. logo
Market Cap: Highest
Employees: Low

ridinilazole

Summit Therapeutics Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to treat infectious diseases, with a lead product candidate called ridinilazole in Phase III clinical trials for Clostridioides difficile infection (CDI).

Tags: Clostridioides difficile, antibiotic, biopharmaceutical, clinical trials, infectious diseases

Symbol: SMMT

Recent Price: $17.89

Industry: Biotechnology

CEO: Mr. Robert W. Duggan

Sector: Healthcare

Employees: 105

Address: One Broadway, Cambridge, MA 02142

Phone: 617 514 7149

Leadership

  • Bob Duggan, CEO & Chairman
  • Dr. Maky Zanganeh, CEO & President
  • Dave Gancarz, Chief Business & Strategy Officer
  • Dr. Urte Gayko, Chief Regulatory, Quality & Pharmacovigilance Officer
  • Dr. Fong Clow, Chief Biometrics Officer
  • Shelley D Spray, Chief Education & Brand Officer
  • Dr. Allen S. Yang, Chief Medical Officer
  • Bhaskar Anand, Head of Finance and Chief Accounting Officer
  • Dr. Betty Chang, Head of Research, Oncology & Inflammation
  • Dr. Andy Dwyer, Head of CMC & Supply Chain
  • Dr. Noam Frey, SVP, Global Medical Affairs
  • Pawan Parihar, Head of Information Technology
  • Dr. Juthamas Sukbuntherng, Head of Clinical Pharmacology & DMPK
  • Robert W. Duggan, CEO & Chairman of the Board
  • Dr. Mahkam (Maky) Zanganeh, CEO, President & Director
  • Manmeet Soni, Chief Operating Officer, Chief Financial Officer & Director
  • Kenneth A. Clark, Lead Independent Director
  • Dr. Robert Booth, Non-Executive Director
  • Dr. Alessandra Cesano, Non-Executive Director
  • Dr. Yu (Michelle) Xia, Director
  • Dr. Mostafa Ronaghi, Non-Executive Director
  • Jeff Huber, Non-Executive Director

Last updated: 2024-12-31